615. Is Ozempic as Magical as It Sounds?
2024-12-12 · 57 min · episode 615 · 8 entities
Asserted relationships
-
0.67 · ×2
evidence rules-v5
han L. Dellgren, and Govind Persad, and Ezekiel J. Emanuel ( The Lancet, 2024). The Coming Wave: Technology, Power, and the Twenty-first Century's Greatest Dilemma , by Mustaf
-
0.40 · ×4
evidence rules-v4
Feed category: Society & Culture
-
0.40 · ×4
evidence rules-v4
Feed category: Documentary
-
0.40 · ×4
evidence rules-v4
Feed author/publisher: Freakonomics Radio + Stitcher
Entities found in this episode
concepts 4
-
0.50 · ×4
evidence rules-v4
Feed category: Society & Culture
-
0.50 · ×4
evidence rules-v4
Feed category: Documentary
-
0.40 · ×4
evidence rules-v4
Feed category: Society & Culture
-
0.40 · ×4
evidence rules-v4
Feed category: Documentary
books 2
-
0.78 · ×2
evidence rules-v5
han L. Dellgren, and Govind Persad, and Ezekiel J. Emanuel ( The Lancet, 2024). The Coming Wave: Technology, Power, and the Twenty-first Century's Greatest Dilemma , by Mustaf
-
0.67 · ×2
evidence rules-v5
han L. Dellgren, and Govind Persad, and Ezekiel J. Emanuel ( The Lancet, 2024). The Coming Wave: Technology, Power, and the Twenty-first Century's Greatest Dilemma , by Mustaf
companys 2
-
0.70 · ×4
evidence rules-v4
Feed author/publisher: Freakonomics Radio + Stitcher
-
0.40 · ×4
evidence rules-v4
Feed author/publisher: Freakonomics Radio + Stitcher
Episode description as stored
In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy.
SOURCES: Ezekiel Emanuel , vice provost for Global Initiatives, co-director of the Health Transformation Institute, and professor at the University of Pennsylvania Perelman School of Medicine.
RESOURCES: " Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal ," by Margot Sanger-Katz ( The New York Times, 2024).
" International Coverage of GLP-1 Receptor Agonists: A Review and Ethical Analysis of Discordant Approaches ," by Johan L. Dellgren, and Govind Persad, and Ezekiel J. Emanuel ( The Lancet, 2024).
The Coming Wave: Technology, Power, and the Twenty-first Century's Greatest Dilemma , by Mustafa Suleyman (2023).
" The Significance of Blockbusters in the Pharmaceutical Industry ," by Alexander Schuhmacher, Markus Hinder, Nikolaj Boger, Dominik Hartl, and Oliver Gassmann ( Nature Reviews Drug Discovery, 2022).
Reinventing American Health Care: How the Affordable Care Act Will Improve Our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System , by Ezekiel J. Emanuel (2014).
" Why I Hope to Die at 75 ," by Ezekiel J. Emanuel ( The Atlantic , 2014).
" Direct-to-Consumer Advertising of Pharmaceuticals ," by Ziad F. Gellad and Kenneth W. Lyles ( The American Journal of Medicine, 2014).
Brothers Emanuel: A Memoir of an American Family , by Ezekiel J. Emanuel (2013).
" Bounds in Competing Risks Models and the War on Cancer ," by Bo E. Honoré and Adriana Lleras-Muney ( Econometrica, 2006).
EXTRAS: " How to Fix Medical Research ," by People I (Mostly) Admire (2024).
" The Suddenly Diplomatic Rahm Emanuel ," by Freakonomics Radio (2023).
" Ari Emanuel Is Never Indifferent ," by Freakonomics Radio (2023).
" Who Pays for Multimillion-Dollar Miracle Cures? " by Freakonomics, M.D. (2023).
" Who Gets the Ventilator? " by Freakonomics Radio (2020).
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.